BioLife Cash Flow To Debt Ratio from 2010 to 2024
| BLFS Stock | USD 17.86 0.33 1.88% |
Cash Flow To Debt Ratio | First Reported 2010-12-31 | Previous Quarter (0.44) | Current Value (0.46) | Quarterly Volatility 7.41170785 |
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife main balance sheet or income statement drivers, such as Interest Expense of 1.9 M, Selling General Administrative of 52.9 M or Total Revenue of 150.4 M, as well as many exotic indicators such as Price To Sales Ratio of 4.71, Dividend Yield of 0.0011 or PTB Ratio of 2.0. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
BioLife | Cash Flow To Debt Ratio |
Latest BioLife Solutions' Cash Flow To Debt Ratio Growth Pattern
Below is the plot of the Cash Flow To Debt Ratio of BioLife Solutions over the last few years. It is BioLife Solutions' Cash Flow To Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
| Cash Flow To Debt Ratio | 10 Years Trend |
|
Cash Flow To Debt Ratio |
| Timeline |
BioLife Cash Flow To Debt Ratio Regression Statistics
| Arithmetic Mean | (2.08) | |
| Coefficient Of Variation | (356.63) | |
| Mean Deviation | 3.55 | |
| Median | (0.18) | |
| Standard Deviation | 7.41 | |
| Sample Variance | 54.93 | |
| Range | 29.5956 | |
| R-Value | 0.44 | |
| Mean Square Error | 47.45 | |
| R-Squared | 0.20 | |
| Significance | 0.1 | |
| Slope | 0.74 | |
| Total Sum of Squares | 769.07 |
BioLife Cash Flow To Debt Ratio History
About BioLife Solutions Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include BioLife Solutions income statement, its balance sheet, and the statement of cash flows. BioLife Solutions investors use historical funamental indicators, such as BioLife Solutions's Cash Flow To Debt Ratio, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may use each financial statement separately, they are all related. The changes in BioLife Solutions's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BioLife Solutions's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BioLife Solutions Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BioLife Solutions. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash Flow To Debt Ratio | (0.44) | (0.46) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioLife Solutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioLife Solutions' short interest history, or implied volatility extrapolated from BioLife Solutions options trading.
Pair Trading with BioLife Solutions
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLife Solutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Solutions will appreciate offsetting losses from the drop in the long position's value.Moving together with BioLife Stock
| 0.66 | CVS | CVS Health Corp Financial Report 1st of May 2024 | PairCorr |
Moving against BioLife Stock
| 0.57 | GCTK | GlucoTrack | PairCorr |
The ability to find closely correlated positions to BioLife Solutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLife Solutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLife Solutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLife Solutions to buy it.
The correlation of BioLife Solutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLife Solutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLife Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioLife Solutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of BioLife Solutions Correlation against competitors. For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.Note that the BioLife Solutions information on this page should be used as a complementary analysis to other BioLife Solutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for BioLife Stock analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is BioLife Solutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (1.52) | Revenue Per Share 3.277 | Quarterly Revenue Growth (0.26) | Return On Assets (0.08) |
The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.